Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell division cycle 27 pseudogene 2 (CDC27P2) is a **pseudogene** in the human genome (chrY:10190377-10192298) that is related to the functional CDC27 gene, but does not encode a functional protein product[1][4][5]. There is no evidence for translation into a protein, and databases state that no function is available for this gene[5]. As a pseudogene, CDC27P2 is not regarded as a therapeutic target, a receptor, enzyme, or any other class of druggable gene product. It is not involved in biological pathways or disease mechanisms, and no drugs or diagnostics are associated with it. **Note:** The true protein-coding gene CDC27 (cell division cycle 27) is an important cell cycle regulator and part of the anaphase-promoting complex, but CDC27P2 is only a non-coding, pseudogene “copy” with no characterized functional or clinical roles[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell division cycle 27 pseudogene 2 (CDC27P2).